Thus, SOX1, SOX2, SOX3 and SOX21 as well as SOX4 were demonstrated to elicit humoral immune responses in small cell lung cancer patients (Gure et al, 2000; Friedman et al, 2004). This evidence concerns the gene SOX2 and small cell lung carcinoma.